Tokyo National Hospital - Academic Profile

Publications

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

Tony Mok , Yi‐Long Wu , Sumitra Thongprasert +16 more

Gefitinib is superior to carboplatin-paclitaxel as an initial treatment for pulmonary adenocarcinoma among nonsmokers or former light smokers in East Asia. The presence in the t...

2009 New England Journal of Medicine 8112 citations

Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland

J.L. Hayward , Paul P. Carbone , Jean-Claude Heuson +3 more

SCOPUS: ar.j

1977 Cancer 626 citations

Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)

Kenji Tamura , Isamu Okamoto , Tatsuhiko Kashii +13 more

The purpose of this study was to evaluate the efficacy of gefitinib and the feasibility of screening for epidermal growth factor receptor (EGFR) mutations among select patients ...

2008 British Journal of Cancer 203 citations

Affiliated Researchers

Institution Info

Type: healthcare
Country: JP
Publications: 3
Citations: 8,941

External Links

Identifiers

ROR: https://ror.org/05asn5035